Sung Lee Sangamo Therapeutics, Inc (SGMO) insider trading activity

SGMO Quotes by TradingView

Sung Lee is EVP, Chief Financial Officer of SANGAMO THERAPEUTICS, INC. Currently has a direct ownership of 88,708 shares of SGMO, which is worth approximately $150,803. The most recent transaction as insider was on Nov 25, 2020, when has been sold 5,042 shares (Common Stock) at a price of $9.77 per share, resulting in proceeds of $49,260. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 88.7K
0% 3M change
0% 12M change
Total Value Held $150,803

Sung Lee Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 25 2020
SELL
Payment of exercise price or tax liability
$49,260 $9.77 p/Share
5,042 Reduced 5.38%
88,708 Common Stock

Also insider at

VIR
Vir Biotechnology, Inc. Healthcare
EVP & Chief Financial Officer
CYTK
CYTOKINETICS INC Healthcare
EVP, Chief Financial Officer
SL

Sung Lee

EVP, Chief Financial Officer
Brisbane, CA

Track Institutional and Insider Activities on SGMO

Follow SANGAMO THERAPEUTICS, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SGMO shares.

Notify only if

Insider Trading

Get notified when an Sangamo Therapeutics, Inc insider buys or sells SGMO shares.

Notify only if

News

Receive news related to SANGAMO THERAPEUTICS, INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SGMO